Uhlig, S <br/><br/>
Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin.  [electronic resource] 

 -  Molecular medicine (Cambridge, Mass.)  May 1996 
 - 373-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1076-1551 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid<br/>6-Ketoprostaglandin F1 alpha--metabolism<br/>Animals<br/>Bronchoconstriction--drug effects<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--pharmacology<br/>DNA Primers<br/>Endotoxins--pharmacology<br/>Female<br/>In Vitro Techniques<br/>Isoenzymes--biosynthesis<br/>Lipopolysaccharides--pharmacology<br/>Lipoxygenase Inhibitors--pharmacology<br/>Lung--drug effects<br/>Microscopy, Electron, Scanning<br/>Platelet Activating Factor--pharmacology<br/>Polymerase Chain Reaction<br/>Prostaglandin Endoperoxides, Synthetic--pharmacology<br/>Prostaglandin-Endoperoxide Synthases--biosynthesis<br/>RNA, Messenger--biosynthesis<br/>Rats<br/>Rats, Wistar<br/>Salmonella<br/>Thromboxane A2--analogs & derivatives<br/>Thromboxane B2--metabolism<br/>Transcription, Genetic--drug effects<br/>Vasoconstrictor Agents--pharmacology